NCT04655378View on ClinicalTrials.gov

Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

October 22, 2020

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2022

Conditions
Rheumatoid PurpuraPediatric ALL
Interventions
OTHER

Mass Sepctrometry

Mass spectrometry (LC/MS) of purified immunoglobulins

Trial Locations (2)

Unknown

CHRU de Montpellier, Montpellier

CHU de Nimes, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER

NCT04655378 - Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura | Biotech Hunter | Biotech Hunter